Eiger BioPharmaceuticals, Inc. Recorded Big Gain
Thu, Mar 17, 2022 at 05:30 PM
Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ) soared at $7.98, representing a gain of 40.2%. On Tue, Mar 15, 2022, EIGR:NASDAQ hit a New 2-Week High of $5.45. The stock got featured on our News Catalysts scanner on Thu, Mar 17, 2022 at 09:47 AM in the 'BIOTECH' category. From Tue, Mar 01, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days
About Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ)
Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases.
Top 10 Gainers:
- Kidpik Corp. (PIK:NASDAQ), 158.15%
- Marrone Bio Innovations, Inc. (MBII:NASDAQ), 49.7%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 45%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 40.25%
- Mullen Automotive Inc. (MULN:NASDAQ), 39.43%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 37.56%
- Orphazyme A/S (ORPH:NASDAQ), 37.4%
- Innodata Inc. (INOD:NASDAQ), 34.33%
- Neonode Inc. (NEON:NASDAQ), 33.02%
- Cingulate Inc. (CING:NASDAQ), 31.62%